Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Finland Speech Therapy Services 2025-12-31
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V To The In Ii.2.4. Mentioned Active Substances With The Possibility Of Closing Within The Framework Of The So-called Op 2025-12-31
Italy Complete, Automated And Integrated Diagnostic System For Carrying Out The Chemical-physical Examination Of Urine And Urinary Sediment 2025-12-31
Germany Conclusion Of A Non-exclusive Framework Agreement For Control Tests And Laboratory Services In The Open House Procedure Of The Westphalia Branch 2025-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Golimumab (atc Code According To Who 2025-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Tocilizumab (atc Code According To Who 2025-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Bosutinib  2025-12-31
Germany Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Bosutinib (atc-code Nach Who: L01ea04) 2025-12-31
Germany Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Golimumab (atc-code Nach Who: L04ab06) 2025-12-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Tocilizumab (atc Code According To Who: L04ac07) 2025-12-31
Whats app